News, events, updates, breakthroughs

Press Releases

News, events, updates, breakthroughs.

Press announcements are archived by release date, searchable by topic:

From: To:


Search  
RSS
Showing 14 results

Latest Press Releases

  • April 03, 2014

    DS & UCSF Collaborate in Research for Neurodegenerative Disease

  • March 31, 2014

    Daiichi Sankyo Initiates Phase 3 ENSURE-AF Study

  • March 24, 2014

    Once-Daily Edoxaban Evaluated in Two Subgroup Analyses of East Asian Patients from the Largest Compa

  • January 21, 2014

    Dr. Mahmoud Ghazzi Named Global Head of Drug Development

  • January 08, 2014

    Daiichi Sankyo Submits SAVAYSA (edoxaban) Tablets New Drug Application to the U.S. FDA

  • January 08, 2014

    Daiichi Sankyo, Virtici and Celdara Medical Announce Collaboration

  • January 07, 2014

    Daiichi Sankyo Submits Edoxaban Marketing Authorization Application to the EMA for Once-Daily Use fo

  • December 19, 2013

    Daiichi Sankyo Submits Supplemental New Drug Application in Japan for LIXIANA

  • December 09, 2013

    Phase 3 Data Show Daiichi Sankyo-s Once-Daily Edoxaban Lowered Incidence of VTE Recurrence and Clini

  • November 19, 2013

    Daiichi Sankyo┬┤s Once-Daily Edoxaban Meets Primary Efficacy Endpoint for Stroke Prevention

  • October 03, 2013

    Daiichi Sankyo, Inc. Makes Two New Executive Appointments

  • September 01, 2013

    Daiichi Sankyo's Once-Daily Edoxaban Shows Comparable Efficacy and Superiority

  • June 06, 2013

    New Guidelines From the American Association of Clinical Endocrinologists (AACE) Identify Welchol

  • April 25, 2013

    Perosphere and Daiichi Sankyo Enter into a Clinical Trial Agreement

Showing 14 results